{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:12:54Z","timestamp":1781075574072,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82071967"],"award-info":[{"award-number":["82071967"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019018","name":"CAMS initiative for innovative medicine","doi-asserted-by":"crossref","award":["CAMS-2018-I2M-3-001"],"award-info":[{"award-number":["CAMS-2018-I2M-3-001"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2016YFC0901500"],"award-info":[{"award-number":["2016YFC0901500"]}]},{"name":"Center for Rare Diseases Research, Chinese Academy of Medical Sciences, Beijing, China","award":["2016ZX310174-4"],"award-info":[{"award-number":["2016ZX310174-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-022-03764-2","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T14:02:51Z","timestamp":1672408971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dynamic PET\/CT scan of 68Ga-FAPI-04 for the optimal acquisition time in suspected malignant hepatic cancer patients"],"prefix":"10.1007","author":[{"given":"Haiqun","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"3764_CR1","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.2967\/jnumed.118.214361","volume":"59","author":"JT Siveke","year":"2018","unstructured":"Siveke JT (2018) Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment. J Nucl Med 59:1412-4. https:\/\/doi.org\/10.2967\/jnumed.118.214361.","journal-title":"J Nucl Med"},{"key":"3764_CR2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, et al (2014) Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl 8:454-63. https:\/\/doi.org\/10.1002\/prca.201300095.","journal-title":"Proteomics Clin Appl"},{"key":"3764_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T, et al (2019) (68)Ga-FAPI PET\/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers. J Nucl Med 60:386-92. https:\/\/doi.org\/10.2967\/jnumed.118.215913.","journal-title":"J Nucl Med"},{"key":"3764_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","volume":"61","author":"C Meyer","year":"2019","unstructured":"Meyer C, Dahlbom M, Lindner T, et al (2019) Radiation dosimetry and biodistribution of (68)Ga-FAPI-46 PET imaging in cancer patients. J Nucl Med 61:1171-1177. https:\/\/doi.org\/10.2967\/jnumed.119.236786.","journal-title":"J Nucl Med"},{"key":"3764_CR5","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/s00259-019-04346-z","volume":"46","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Heussel CP, Lindner T, et al (2019) FAPI-PET\/CT improves staging in a lung cancer patient with cerebral metastasis. Eur J Nucl Med Mol Imaging 46:1754-5. https:\/\/doi.org\/10.1007\/s00259-019-04346-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3764_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, et al (2019) (68)Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med 60:801-5. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"key":"3764_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2967\/jnumed.120.245084","volume":"62","author":"F Giesel","year":"2020","unstructured":"Giesel F, Adeberg S, Syed M, et al (2020) FAPI-74 PET\/CT Using Either (18)F-AlF or Cold-kit (68)Ga-labeling: Biodistribution, Radiation Dosimetry and Tumor Delineation in Lung Cancer Patients. J Nucl Med 62:201-207. https:\/\/doi.org\/10.2967\/jnumed.120.245084.","journal-title":"J Nucl Med"},{"key":"3764_CR8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, et al (2018) Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. J Nucl Med 59:1415-22. https:\/\/doi.org\/10.2967\/jnumed.118.210443.","journal-title":"J Nucl Med"},{"key":"3764_CR9","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, et al (2020) Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging 47:1820-32. https:\/\/doi.org\/10.1007\/s00259-020-04769-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3764_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00259-020-04882-z","volume":"48","author":"X Shi","year":"2021","unstructured":"Shi X, Xing H, Yang X, et al (2021) Fibroblast imaging of hepatic carcinoma with (68)Ga-FAPI-04 PET\/CT: a pilot study in patients with suspected hepatic nodules. Eur J Nucl Med Mol Imaging 48:196-203. doi:https:\/\/doi.org\/10.1007\/s00259-020-04882-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3764_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00259-020-05070-9","volume":"48","author":"X Shi","year":"2021","unstructured":"Shi X, Xing H, Yang X, et al (2021) Comparison of PET imaging of activated fibroblasts and (18)F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study. Eur J Nucl Med Mol Imaging 48: 1593-1603. https:\/\/doi.org\/10.1007\/s00259-020-05070-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3764_CR12","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1158\/1078-0432.CCR-12-0644","volume":"18","author":"E Fischer","year":"2012","unstructured":"Fischer E, Chaitanya K, Wuest T, et al (2012) Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies. Clin Cancer Res 18:6208-18. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0644.","journal-title":"Clin Cancer Res"},{"key":"3764_CR13","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.2967\/jnumed.118.220566","volume":"260","author":"T Langbein","year":"2019","unstructured":"Langbein T, Weber WA, Eiber M (2019) Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine. J Nucl Med 260:13S-9S. https:\/\/doi.org\/10.2967\/jnumed.118.220566.","journal-title":"J Nucl Med"},{"key":"3764_CR14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, et al (2018) A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. J Nucl Med 59:1423-9. https:\/\/doi.org\/10.2967\/jnumed.118.210435.","journal-title":"J Nucl Med"},{"key":"3764_CR15","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","volume":"60","author":"A Loktev","year":"2019","unstructured":"Loktev A, Lindner T, Burger EM, et al (2019) Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention. J Nucl Med 60:1421-9. https:\/\/doi.org\/10.2967\/jnumed.118.224469.","journal-title":"J Nucl Med"},{"key":"3764_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116683","volume":"10","author":"F Liu","year":"2015","unstructured":"Liu F, Qi L, Liu B, et al (2015) Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis. PLoS One 10:e0116683. https:\/\/doi.org\/10.1371\/journal.pone.0116683.","journal-title":"PLoS One"},{"key":"3764_CR17","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3349\/ymj.2014.55.6.1467","volume":"55","author":"A Musto","year":"2014","unstructured":"Musto A, Grassetto G, Marzola MC, et al (2014) Role of 18F-FDG PET\/CT in the carcinoma of the uterus: a review of literature. Yonsei Med J 55:1467-72. https:\/\/doi.org\/10.3349\/ymj.2014.55.6.1467.","journal-title":"Yonsei Med J"},{"key":"3764_CR18","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1007\/s00259-020-04859-y","volume":"47","author":"M Syed","year":"2020","unstructured":"Syed M, Flechsig P, Liermann J, et al (2020) Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers. Eur J Nucl Med Mol Imaging 47:2836-2845. https:\/\/doi.org\/10.1007\/s00259-020-04859-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3764_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s0344-0338(97)80102-1","volume":"193","author":"B Davidson","year":"1997","unstructured":"Davidson B, Goldberg I, Kopolovic J (1997) Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix. Pathol Res Pract 193:491-5. https:\/\/doi.org\/10.1016\/s0344-0338(97)80102-1.","journal-title":"Pathol Res Pract"},{"key":"3764_CR20","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/jm500031w","volume":"57","author":"K Jansen","year":"2014","unstructured":"Jansen K, Heirbaut L, Verkerk R, et al (2014) Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP). J Med Chem 57:3053-74. https:\/\/doi.org\/10.1021\/jm500031w.","journal-title":"J Med Chem"},{"issue":"5","key":"3764_CR21","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1007\/s00259-020-05095-0","volume":"48","author":"W Guo","year":"2021","unstructured":"Guo W, Pang Y, Yao L, et al (2021) Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [(68)Ga]Ga-FAPI-04 PET\/CT versus MRI and [(18)F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging 48(5):1604-1617. https:\/\/doi.org\/10.1007\/s00259-020-05095-0.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03764-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-022-03764-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03764-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T14:04:30Z","timestamp":1672409070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-022-03764-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":21,"alternative-id":["3764"],"URL":"https:\/\/doi.org\/10.1007\/s00261-022-03764-2","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"28 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Peking Union Medical College Hospital ethics committee (Ethical Review Number: ZS-1810).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}